{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:36:50Z","timestamp":1787017010586,"version":"build-2736575974"},"reference-count":24,"publisher":"BMJ","license":[{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.m3325","type":"journal-article","created":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T10:40:44Z","timestamp":1599561644000},"page":"m3325","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":73,"title":["Testing for SARS-CoV-2 antibodies"],"prefix":"10.1136","author":[{"given":"Jessica","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"key":"2020090807400699000_370.sep08_2.m3325.1","doi-asserted-by":"crossref","unstructured":"Petherick A. Developing antibody tests for SARS-CoV-2. Lancet 2020;395:1101-2.","DOI":"10.1016\/S0140-6736(20)30788-1"},{"key":"2020090807400699000_370.sep08_2.m3325.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1808"},{"key":"2020090807400699000_370.sep08_2.m3325.3","doi-asserted-by":"crossref","unstructured":"Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med 2020;173:262-7.","DOI":"10.7326\/M20-1495"},{"key":"2020090807400699000_370.sep08_2.m3325.4","unstructured":"Lind S. GPs to provide covid antibody testing for patients who have bloods taken. Pulse; 2020. http:\/\/www.pulsetoday.co.uk\/news\/gps-to-provide-covid-antibody-testing-for-patients-who-have-bloods-taken\/20040894.article ."},{"key":"2020090807400699000_370.sep08_2.m3325.5","doi-asserted-by":"crossref","unstructured":"Deeks JJ Dinnes J Takwoingi Y Cochrane COVID-19 Diagnostic Test Accuracy Group . Antibody tests for identification of current and past infection with SARS-CoV-2 [PubMed]. Cochrane Database Syst Rev 2020;6:CD013652.","DOI":"10.1002\/14651858.CD013652"},{"key":"2020090807400699000_370.sep08_2.m3325.6","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.16.20066787%J"},{"key":"2020090807400699000_370.sep08_2.m3325.7","doi-asserted-by":"crossref","unstructured":"Long Q-X, Tang X-J, Shi Q-L, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 2020;26:1200-4.","DOI":"10.1038\/s41591-020-0965-6"},{"key":"2020090807400699000_370.sep08_2.m3325.8","doi-asserted-by":"crossref","unstructured":"Whiting PF, Rutjes AWS, Westwood ME, Mallett S; QUADAS-2 Steering Group. A systematic review classifies sources of bias and variation in diagnostic test accuracy studies. J Clin Epidemiol 2013;66:1093-104.","DOI":"10.1016\/j.jclinepi.2013.05.014"},{"key":"2020090807400699000_370.sep08_2.m3325.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2025179"},{"key":"2020090807400699000_370.sep08_2.m3325.10","unstructured":"Public Health England. Sero-surveillance of covid-19. 2020. https:\/\/www.gov.uk\/government\/publications\/national-covid-19-surveillance-reports\/sero-surveillance-of-covid-19."},{"key":"2020090807400699000_370.sep08_2.m3325.11","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.21.20132449%J"},{"key":"2020090807400699000_370.sep08_2.m3325.12","doi-asserted-by":"crossref","unstructured":"Le Bert N, Tan AT, Kunasegaran K, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 2020;584:457-62.","DOI":"10.1038\/s41586-020-2550-z"},{"key":"2020090807400699000_370.sep08_2.m3325.13","doi-asserted-by":"crossref","unstructured":"Duan K, Liu B, Li C, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A 2020;117:9490-6.","DOI":"10.1073\/pnas.2004168117"},{"key":"2020090807400699000_370.sep08_2.m3325.14","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.30.20047365%J"},{"key":"2020090807400699000_370.sep08_2.m3325.15","doi-asserted-by":"crossref","unstructured":"Fierz W, Walz B. Antibody dependent enhancement due to original antigenic sin and the development of SARS. Front Immunol 2020;11:1120.","DOI":"10.3389\/fimmu.2020.01120"},{"key":"2020090807400699000_370.sep08_2.m3325.16","doi-asserted-by":"crossref","unstructured":"Hart JT. The inverse care law. Lancet 1971;1:405-12.","DOI":"10.1016\/S0140-6736(71)92410-X"},{"key":"2020090807400699000_370.sep08_2.m3325.17","doi-asserted-by":"crossref","unstructured":"Andersson M, Low N, French N, et al. Rapid roll out of SARS-CoV-2 antibody testing-a concern. BMJ 2020;369:m2420.","DOI":"10.1136\/bmj.m2420"},{"key":"2020090807400699000_370.sep08_2.m3325.18","unstructured":"Scottish Government. COVID-19 antibody testing 2020. 2020 https:\/\/www.gov.scot\/news\/covid-19-antibody-testing-1"},{"key":"2020090807400699000_370.sep08_2.m3325.19","unstructured":"Martin J. Covid-19 testing: a national strategy. Royal College of Pathologists 2020. https:\/\/www.rcpath.org\/uploads\/assets\/2e8d8771-f85a-408a-b5c8e68969cd21d5\/cbcb4f30-d8f8-40fe-ba8cdef3e6803ee4\/RCPath-COVID-19-testing-a-national-strategy.pdf"},{"key":"2020090807400699000_370.sep08_2.m3325.20","doi-asserted-by":"crossref","unstructured":"Watson J, de Salis I, Banks J, Salisbury C. What do tests do for doctors? A qualitative study of blood testing in UK primary care. Fam Pract 2017;34:735-9.","DOI":"10.1093\/fampra\/cmx051"},{"key":"2020090807400699000_370.sep08_2.m3325.21","doi-asserted-by":"crossref","unstructured":"Petrie KJ, Sherriff R. Normal diagnostic test results do not reassure patients. Evid Based Med 2014;19:14.","DOI":"10.1136\/eb-2013-101393"},{"key":"2020090807400699000_370.sep08_2.m3325.22","doi-asserted-by":"crossref","unstructured":"Rolfe A, Burton C. Reassurance after diagnostic testing with a low pretest probability of serious disease: systematic review and meta-analysis. JAMA Intern Med 2013;173:407-16.","DOI":"10.1001\/jamainternmed.2013.2762"},{"key":"2020090807400699000_370.sep08_2.m3325.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2017739"},{"key":"2020090807400699000_370.sep08_2.m3325.24","doi-asserted-by":"crossref","unstructured":"Kofler N, Baylis F. Ten reasons why immunity passports are a bad idea. Nature 2020;581:379-81.","DOI":"10.1038\/d41586-020-01451-0"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.m3325","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.m3325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:09:15Z","timestamp":1601078955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.m3325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,8]]},"references-count":24,"alternative-id":["10.1136\/bmj.m3325"],"URL":"https:\/\/doi.org\/10.1136\/bmj.m3325","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,8]]}}}